Pamela Landsman-Blumberg

SVP, Real-World Evidence & HEOR Strategy

Pamela Landsman-Blumberg is Senior Vice President of Real-World Evidence & HEOR Strategy at Magnolia Market Access. Pam is an industry-recognized subject matter expert in RWD evaluation and RWE generation. Her work designing and conducting outcomes research studies and implementing related strategies across the product lifecycle has improved the evidence- and value-based decision-making of industry investors, C-suite members, payers, providers, and patients.

Throughout her career, Pam has designed and conducted observational studies and single arm trials with historical and concurrent controls, utilizing all sources of real-world secondary data and modes of data collection, including medical chart review, natural language processing, and prospective collection. Her experience includes evaluating clinical trial feasibility, patient identification and prescriber profiling, estimating disease incidence and prevalence, designing and evaluating value-based contracts, developing predictive models, estimating the burden and cost of illness, measuring drug adherence and persistence, and conducting comparative safety and effectiveness studies.

Prior to joining Magnolia, Pam worked at several consultancies and data providers, building and growing HEOR and RWE divisions, advising clients on all aspects of fit-for-purpose real-world database creation and identification and real-world evidence generation strategies for the US, Europe, and Asia markets, and serving as strategic lead on industry-funded engagements. In addition, Pam spent 13 years with Merck & Company in various HEOR, managed care marketing, and corporate health and wellness roles. She is a longstanding member of ISPE and ISPOR and is a member representative to ISPOR’s Institutional Council. She served a 2-year term as Council Chair.

Pam holds a Bachelor of Science from the University of Connecticut at Storrs, a Master of Public Health in biostatistics from the University of North Carolina at Chapel Hill, and a Doctor of Public Health in health policy and management from the University of Michigan at Ann Arbor.